Stock ODPVY ODONTOPREV S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Odontoprev S.A. OTC Markets

Equities

ODPVY

US67612A1060

End-of-day quote OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Odontoprev S.A. -.--% -.--%
05-08 Transcript : Odontoprev S.A., Q1 2024 Earnings Call, May 08, 2024
05-08 Odontoprev S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • This company will be of major interest to investors in search of a high dividend stock.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company appears highly valued given the size of its balance sheet.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Managed Healthcare

1st Jan change Capi. Investor Rating ESG Refinitiv
ODONTOPREV S.A. Stock Odontoprev S.A.
-.--% 1.17B -
HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A. Stock Hapvida Participações e Investimentos S.A.
-10.34% 5.7B
C
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ODPV3 Stock
  4. ODPVY Stock
  5. Ratings Odontoprev S.A.